Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer
Kim Tam Bui, Melina L Willson, Shom Goel, et al.
Cochrane library (2020)
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Hormone-Related and Drug-Induced Osteoporosis: A Cellular and Molecular Overview
Li-Ting Wang, Li-Ru Chen, Kuo-Hu Chen
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5814-5814
Open Access | Times Cited: 73
Therapeutic evolution in HR+/HER2- breast cancer: from targeted therapy to endocrine therapy
Lu-Qi Cao, Haidong Sun, Yuhao Xie, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 10
Selection of appropriate biomarkers to monitor effectiveness of ovarian function suppression in pre-menopausal patients with ER+ breast cancer
Kelly McCann, Shari Goldfarb, Tiffany A. Traina, et al.
npj Breast Cancer (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 7
Neoadjuvant chemotherapy for breast cancer: an evaluation of its efficacy and research progress
Yushi Chen, Qi Yu, Kuansong Wang
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 15
Long-term outcomes of bilateral salpingo-oophorectomy in women with personal history of breast cancer
Hend Hassan, Tameera Rahman, Andrew Bacon, et al.
BMJ Oncology (2025) Vol. 4, Iss. 1, pp. e000574-e000574
Open Access
Impact of risk and lifestyle factors on therapy goals in the treatment of breast cancer and gynecological cancer patients with integrative medicine
Katharina Seitz, Anna-Katharin Theuser, Sophia Antoniadis, et al.
Archives of Gynecology and Obstetrics (2025)
Open Access
Targeting sex steroid biosynthesis for breast and prostate cancer therapy
Matti Poutanen, Malin Hagberg Thulin, Pirkko Härkönen
Nature reviews. Cancer (2023) Vol. 23, Iss. 10, pp. 686-709
Closed Access | Times Cited: 12
Prognosis, clinicopathological characteristics, and treatment patterns of patients with ER-intermediate-positive breast cancer undergoing long-term follow-up
Naoya Matsumoto, Yumi Wanifuchi‐Endo, Takashi Fujita, et al.
ESMO Open (2025) Vol. 10, Iss. 4, pp. 104508-104508
Open Access
Prevention and Co-Management of Breast Cancer-Related Osteoporosis Using Resveratrol
Christine Meyer, Aranka Brockmueller, Constanze Buhrmann, et al.
Nutrients (2024) Vol. 16, Iss. 5, pp. 708-708
Open Access | Times Cited: 3
Ovarian Function Suppression With Luteinizing Hormone-Releasing Hormone Agonists for the Treatment of Hormone Receptor-Positive Early Breast Cancer in Premenopausal Women
Yen‐Shen Lu, Andrea Li Ann Wong, Hee-Jeong Kim
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 23
Breast Cancer Risk and Breast-Cancer-Specific Mortality following Risk-Reducing Salpingo-Oophorectomy in BRCA Carriers: A Systematic Review and Meta-Analysis
Faiza Gaba, Oleg Blyuss, Alex Tan, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1625-1625
Open Access | Times Cited: 8
Prognostic factors and benefit populations of ovarian function suppression in premenopausal HR+/HER2+ early‐stage breast cancer patients who received trastuzumab: Evidence from a real‐world study with long‐term follow‐up
Jie Ju, Songlin Gao, Jiayu Wang, et al.
Thoracic Cancer (2024) Vol. 15, Iss. 6, pp. 439-447
Open Access | Times Cited: 2
Ovarian Suppression: Early Menopause, Late Effects
Chaya Goldberg, M Greenberg, Alexandra Noveihed, et al.
Current Oncology Reports (2024) Vol. 26, Iss. 5, pp. 427-438
Closed Access | Times Cited: 2
Letrozole delays acquisition of water maze task in female BALB/c mice: Possible involvement of anxiety
Jacek Mamczarz, Malcolm V. Lane, István Merchenthaler
Hormones and Behavior (2024) Vol. 162, pp. 105524-105524
Open Access | Times Cited: 2
Breast Cancer Index in Premenopausal Women With Early-Stage Hormone Receptor–Positive Breast Cancer
Ruth O’Regan, Yi Zhang, Gini F. Fleming, et al.
JAMA Oncology (2024) Vol. 10, Iss. 10, pp. 1379-1379
Closed Access | Times Cited: 2
Systemic hormone therapy after breast and gynecological cancers: an Italian expert group consensus opinion
Angelo Cagnacci, Paola Villa, G. Grassi, et al.
Climacteric (2024) Vol. 28, Iss. 1, pp. 4-14
Closed Access | Times Cited: 2
Oncotype DX Recurrence Score in premenopausal women
Shiliang Zhang, Kasey C. Fitzsimmons, Sara A. Hurvitz
Therapeutic Advances in Medical Oncology (2022) Vol. 14
Open Access | Times Cited: 9
Gynecological management of the breast cancer survivor
Mary Kathryn Abel, Tamandra Morgan, Alisha Othieno, et al.
Best Practice & Research Clinical Obstetrics & Gynaecology (2022) Vol. 82, pp. 69-80
Closed Access | Times Cited: 8
Oophorectomy in Premenopausal Patients with Estrogen Receptor-Positive Breast Cancer: New Insights into Long-Term Effects
Fatima Khan, Kristin E. Rojas, Matthew Schlumbrecht, et al.
Current Oncology (2023) Vol. 30, Iss. 2, pp. 1794-1804
Open Access | Times Cited: 4
Can We Use Artificial Intelligence Cluster Analysis to Identify Patients with Metastatic Breast Cancer to the Spine at Highest Risk of Postoperative Adverse Events?
Mitchell S. Fourman, Layla Siraj, Julia B. Duvall, et al.
World Neurosurgery (2023) Vol. 174, pp. e26-e34
Open Access | Times Cited: 4
Sex differences in the cardiovascular effects of GnRH analogues
Matthew Wei Shen Lim, Angela K Lucas‐Herald, Avril Mason, et al.
Journal of Endocrinology (2024)
Open Access | Times Cited: 1
Bone-active drugs in premenopausal women with breast cancer under hormone-deprivation therapies
Maria Francesca Birtolo, Rebecca Pedersini, Andrea Palermo, et al.
European Journal of Endocrinology (2024) Vol. 191, Iss. 2, pp. 117-125
Closed Access | Times Cited: 1
A narrative review: research progress of adjuvant intensive endocrine therapy for early breast cancer
Hunan Ye, Guang Lin, Xiaojia Wang
Translational Breast Cancer Research (2024) Vol. 5, pp. 20-20
Open Access | Times Cited: 1
Safety and efficacy of topical testosterone in breast cancer patients receiving ovarian suppression and aromatase inhibitor therapy
Patrícia Taranto, Diogo de Brito Sales, Fernando Cotait Maluf, et al.
Breast Cancer Research (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 1
Clinical Management of Ovarian Function Suppression in Premenopausal Women With Breast Cancer: A Survey of Members of ASCO
Catherine M. Kelly, Kathleen Bennett, Caitriona Cahir, et al.
JCO Oncology Practice (2024)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top